Comparison of helicobacter pylori eradication rate with quadruple therapy containing gemifloxacin versus clarithromycin in dyspeptic patients referring to Rasool Akram Hospital 2013

Trial Profile

Comparison of helicobacter pylori eradication rate with quadruple therapy containing gemifloxacin versus clarithromycin in dyspeptic patients referring to Rasool Akram Hospital 2013

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Clarithromycin (Primary) ; Gemifloxacin (Primary) ; Amoxicillin; Bismuth salicylate; Omeprazole
  • Indications Dyspepsia; Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2013 Recruitment complete, according to the Iranian Registry of Clinical Trials.
    • 11 May 2013 Recruitment is expected to complete on the 8th of June 2013
    • 11 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top